2024

1. Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease

   Annals of Hematology

2. Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma

   Blood, Vol. 143, Núm. 7, pp. 597-603